# Distal Evaluation of Functional Performance with Intravascular Sensors to Assess the Narrowing Effect: Guided Physiologic Stenting

Study · id `cardio:ct-nct04451044` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04451044](<https://clinicaltrials.gov/study/NCT04451044>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04451044

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is enrolling by invitation. It plans to enroll 3212 participants.

## Technical summary

Registry record NCT04451044. Randomized; double masking; primary purpose treatment. Start 2021-06-17 (actual); primary completion 2026-06 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 3212 participants (planned count; ClinicalTrials.gov record NCT04451044, source copy `cardio:ctgov-nct04451044-2025-01-20`, retrieved 2026-10-26)
- Started: 2021-06-17 (actual) (ClinicalTrials.gov record NCT04451044, source copy `cardio:ctgov-nct04451044-2025-01-20`, retrieved 2026-10-26)
- Primary completion: 2026-06 (anticipated) (ClinicalTrials.gov record NCT04451044, source copy `cardio:ctgov-nct04451044-2025-01-20`, retrieved 2026-10-26)
- Completion: 2028-06 (anticipated) (ClinicalTrials.gov record NCT04451044, source copy `cardio:ctgov-nct04451044-2025-01-20`, retrieved 2026-10-26)
- Countries: United States; Australia; Austria; Canada; Denmark; France; Germany; Israel; Italy; Mexico; Netherlands; Poland; Portugal; South Korea; Spain; Sweden; Switzerland; United Kingdom (ClinicalTrials.gov record NCT04451044, source copy `cardio:ctgov-nct04451044-2025-01-20`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "ENROLLING\_BY\_INVITATION" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04451044-2025-01-20`, retrieved 2026-10-26)

## The registry's words

- Brief title: Distal Evaluation of Functional Performance with Intravascular Sensors to Assess the Narrowing Effect: Guided Physiologic Stenting
- Acronym: DEFINE GPS
- Condition: Coronary Artery Disease
- Condition: Ischemic Heart Disease
- Intervention (Device): Philips SyncVision system with Philips pressure wires
- Intervention (Procedure): standard of care angiographically-guided PCI
- Lead sponsor: Philips Clinical & Medical Affairs Global
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry lists this organization as the lead sponsor: Philips Clinical & Medical Affairs Global (`cardio:org-philips-clinical-medical-affairs-global`)

## Provenance

Content hash: 618fd7ff34032e1b4694223e799d52407415594005a1614e6b121cefbad222d7
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
